No profile data available.
Korean Drug Co., Ltd. (014570.KQ) is a healthcare company in the brain and nerve treatment drugs industry, based in Seoul, South Korea.
It reported revenue of 62.51 billion KRW for fiscal year 2025, down 14.4% from fiscal year 2024, and net income of 6.51 billion KRW. Its market capitalization was 34.53 billion KRW as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
, Ltd. manufactures and sells medicines for treating various diseases in South Korea.
Korean Drug reported 62.51 billion KRW in revenue for fiscal year 2025, down 14.4% from 73.00 billion KRW in fiscal year 2024.
34.53 billion KRW as of October 8, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include SK Biopharmaceuticals Co., Ltd. (326030.KS), Whan In Pharm Co.,Ltd. (016580.KS), Shaperon Inc. (378800.KQ).